Home / Inspections / 1264281

FDA Inspection 1264281 — Carter BloodCare - Irving

Carter BloodCare - Irving — FEI 3003103575

The FDA completed an inspection of Carter BloodCare - Irving on March 13, 2025 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 13, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Irving, TX (United States)

Facility

Other inspections at this facility

  • 1196992 (NAI Thu Feb 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067145 (NAI Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964991 (NAI Wed Mar 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864912 (NAI Wed Feb 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 761809 (NAI Wed Jan 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources